M
Marta Frigerio
Researcher at University of Bologna
Publications - 13
Citations - 508
Marta Frigerio is an academic researcher from University of Bologna. The author has contributed to research in topics: Liver function & QT interval. The author has an hindex of 7, co-authored 12 publications receiving 460 citations.
Papers
More filters
Journal ArticleDOI
Hepatocellular carcinoma in non-cirrhotic liver: A reappraisal
TL;DR: Overall survival strictly dependent on tumour burden (and its recurrence) and barely influenced by liver function.
Journal ArticleDOI
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience
Federica Mirici-Cappa,Annagiulia Gramenzi,V. Santi,Andrea Zambruni,Antonio Di Micoli,Marta Frigerio,Francesca Maraldi,Maria Anna Di Nolfo,Paolo Poggio,Luisa Benvegnù,Gianludovico Rapaccini,Fabio Farinati,Marco Zoli,Franco Borzio,Edoardo G. Giannini,Eugenio Caturelli,Mauro Bernardi,Franco Trevisani +17 more
TL;DR: The overall applicability of radical or effective HCC treatments was unaffected by old age, however, treatment distribution differed, elderly individuals being more frequently treated with percutaneous procedures and less frequently with resection or TACE.
Journal ArticleDOI
The changing scenario of hepatocellular carcinoma over the last two decades in Italy.
V. Santi,Daniela Buccione,Antonio Di Micoli,G. Fatti,Marta Frigerio,Fabio Farinati,Paolo Poggio,Gianludovico Rapaccini,Maria Anna Di Nolfo,Luisa Benvegnù,Marco Zoli,Franco Borzio,Edoardo G. Giannini,Eugenio Caturelli,Maria Chiaramonte,Mauro Bernardi,Franco Trevisani +16 more
TL;DR: The survival improvement observed until 2001 was due to an increasing number of tumours diagnosed in early stages and in a background of compensated cirrhosis, and a growing and better use of locoregional treatments, and national policies aimed at implementing surveillance programmes for at risk patients.
Journal ArticleDOI
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance.
Tommaso Stroffolini,Franco Trevisani,Giovanbattista Pinzello,Franco Brunello,Maurizio A. Tommasini,Massimo Iavarone,Vito Di Marco,Fabio Farinati,Paolo Poggio,Franco Borzio,Mauro Borzio,Eugenio Caturelli,Maria Anna Di Nolfo,Marta Frigerio,Giuseppina Brancaccio,Giovanni Battista Gaeta +15 more
TL;DR: HCC is characterised by a growing prevalence of elderly patients and cases unrelated to hepatitis virus infections, particularly amongst non-viral patients, and the application of surveillance must be implemented.
Journal ArticleDOI
C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
Giulia Magini,Mohsen Farsad,Marta Frigerio,Carla Serra,Antonio Colecchia,Elio Jovine,Marco Vivarelli,V. Feletti,Rita Golfieri,Corrado Patti,Stefano Fanti,Roberto Franchi,Filippo Lodi,Stefano Boschi,Mauro Bernardi,Franco Trevisani +15 more
TL;DR: When the goal is differentiating FNH from liver neoplasms, AC PET offered no additional diagnostic advantage over what is achieved with FDG PET.